参考文献/References:
[1] Lee S,Lee CY,Kim DJ,et al.Pathologic correlation of serum carcinoembryonic antigen and cytokeratin 19 fragment in resected nonsmall cell lungcancer[J].The Korean J Thorac Cardiovasc Surg,2013,46(3); 192-196.
[2] 陈道宝,杨红健,陈 波,等.组织多肽特异性抗原与血管内皮生长因子与乳腺癌患者病理分级关系研究[J].中国生化药物杂志,2015,35(5):121-123.
Chen DB,Yang HJ,Chen B,et al.Study on expression of TPS,VEGF ofbeast cancer patients and relationship with clinical pathological[J].ChineseJournal of Biochemical and Pharmaceutics,2015,35(5):121-123.
[3] Mumbarkar PP,Raste AS,Ghadge MS.Significance of tumor markers in lung cancer[J].Indian J Clin Biochem,2006,21(1):173-176.
[4] Pina TC,Zapata IT,Hemandez FC,et al.Tumour ma-rkers in serum,bronchoalveolar lavage and biopsy cytosol in lung carcinoma:what environment lendsthe optimum diagnostic yield?[J].Clin Chim Acta,2001,305(1/2):27-34.
[5] 张雪松,翟海军.肿瘤标志物在非小细胞肺癌诊断中的价值[J].检验医学与临床,2011,8(18):2299-2300.
Zhang XS,Zhai HJ.The value of tumor marker in diagnosis of non-small cell lung cancer[J].Laboratory Medicine and Clinic,2011,8(18):2299-2300.
[6] 易甲其,范艳平,周宁加,等.血清PTX-3,CYFRA21-1和TPS在非小细胞肺癌中的变化及临床意义[J].现代检验医学杂志,2015,30(5):58-61.
Yi JQ,Fan YP,Zhou NJ,et al.Changes and clinical significance ofserum PTX-3,CYFRA 21-1,TPS in non-small cell lung cancer[J].Journal of Modern Laboratory Medicine,2015,30(5):58-61.
[7] 江 红,李佩章,雷考宁,等.血清肿瘤标志物联合检测提高肺癌诊断的价值[J].中华实用诊断与治疗杂志,2009,23(5):468-470.
Jiang H,Li PZ,Lei KN,et al.The value of serum tumor markers combined detection improve lung cancer diagnosis[J].Journal of Chinese PracticalDiagnosis and Therapy,2009,23(5):468-470.
[8] 倪 然,黄永杰.血清基质金属蛋白酶9、组织多肽特异性抗原水平变化与肺癌患者TNM分期的关联性分析[J].国外医学·医学地理分册,2018,39(2):134-136.
Ni R,Huang YJ.Correlation analysis of serum matrix metalloproteinase 9,the level of tissue polypeptide specific antigen and TNM staging in patients with lung cancer[J].Foreign Medical Science·Section of Medgeography,2018,39(2):134-136.
[9] Lin JT.Screening of gastric cancer:who,when,and how[J].Clin Gastroenterol Hepatol,2014,12(1):135-138.
[10] Mukoubayashi C,Yanaoka K,Ohata H,et al.Serum pepsinogen andgasric cancer screening[J].Intern Med,2007,46(6):261-266.
[11] 漆丹萍,郑海燕.血清骨桥蛋白、胃癌相关抗原和组织多肽特异性抗原诊断胃癌的临床价值[J].实用癌症杂志,2017,32(10):1574-1576,1583.
Qi DP,Zheng HY.Clinical value of serum levels of OPN,MG7-Ag and TPS inthe diagnosis of gastric cancer[J].The Practical Journal of Cancer,2017,32(10):1574-1576,1583.
相似文献/References:
[1]张 萍a,王红义b,杨迎桂a,等.血清CEA,ProGRP,NSE和CYFRA21-1联合检测在肺癌诊断中的应用研究[J].现代检验医学杂志,2016,31(02):56.[doi:10.3969/j.issn.1671-7414.2016.02.017]
ZHANG Pinga,WANG Hong-yib,YANG Ying-guia,et al.Clinical Application of Combined Detection
of CEA,ProGRP,NSE and CYFRA21-1 in Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(06):56.[doi:10.3969/j.issn.1671-7414.2016.02.017]
[2]刁 雪,彭兰欢,曾婷婷,等.血细胞计数和D-二聚体检测
在肺癌并发血栓患者中的变化研究[J].现代检验医学杂志,2015,30(01):68.[doi:10.3969/j.issn.1671-7414.2015.01.018]
DIAO Xue,PENG Lan-huan,ZENG Ting-ting,et al.Analysis of the Changes of Blood Cell Count and D-dimer
in Lung Cancer Patients with Thrombosis[J].Journal of Modern Laboratory Medicine,2015,30(06):68.[doi:10.3969/j.issn.1671-7414.2015.01.018]
[3]汪奇云,刘和录,华建江,等.血浆miR-142-5p在肺癌早期诊断中的价值研究[J].现代检验医学杂志,2016,31(06):74.[doi:10.3969/j.issn.1671-7414.2016.06.020]
WANG Qi-yun,LIU He-lu,HUA Jian-jiang,et al.Value of Plasma miR-142-5p in the Early Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(06):74.[doi:10.3969/j.issn.1671-7414.2016.06.020]
[4]季红兵,唐芹芳,陈思聪,等.血清肿瘤标志物HE4对肺癌的诊断价值[J].现代检验医学杂志,2017,32(02):110.[doi:10.3969/j.issn.1671-7414.2017.02.030]
JI Hong-bin,TANG Qin-fang,CHEN Si-cong,et al.Application of Serum HE4 in the Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2017,32(06):110.[doi:10.3969/j.issn.1671-7414.2017.02.030]